4.91
0.37 (8.15%)
| Penutupan Terdahulu | 4.54 |
| Buka | 4.48 |
| Jumlah Dagangan | 53,842 |
| Purata Dagangan (3B) | 692,006 |
| Modal Pasaran | 3,624,940 |
| Harga / Pendapatan (P/E TTM) | 0.019 |
| Harga / Jualan (P/S) | 0.290 |
| Harga / Buku (P/B) | 30.42 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 14 Aug 2025 |
| Margin Keuntungan | -48.26% |
| Margin Operasi (TTM) | -165.23% |
| EPS Cair (TTM) | 264.12 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -42.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 10.57% |
| Nisbah Semasa (MRQ) | 1.53 |
| Aliran Tunai Operasi (OCF TTM) | -4.47 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -1.48 M |
| Pulangan Atas Aset (ROA TTM) | -53.50% |
| Pulangan Atas Ekuiti (ROE TTM) | -120.16% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | ReShape Lifesciences, Inc. | Bercampur | Bercampur |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.0 |
| Purata | -0.93 |
|
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 10.63% |
| % Dimiliki oleh Institusi | 0.73% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |